TY - CHAP A1 - Brophy, V H A1 - Jarvik, G P A1 - Furlong, C E T1 - PON1 polymorphisms. Y1 - 2002// N1 - R826886C002 N1 - R826886 N1 - R831709 SP - 53 EP - 77 ER - TY - CHAP A1 - Costa, L G A1 - Li, W A1 - Richter, R J A1 - Shih, D M A1 - Lusis, A J A1 - Furlong, C E T1 - PON1 and organophosphate toxicity. Chapter 8. Y1 - 2002// N1 - R826886C002 SP - 165 EP - 183 PB - Kluwer Academic Press ER - TY - CHAP A1 - Costa, L G A1 - Furlong, C E T1 - Perspectives in PON1 research. Y1 - 2002// N1 - R826886C002 N1 - R826886 SP - 197 EP - 210 ER - TY - JOUR A1 - Brophy, V H A1 - Hastings, M D A1 - Clendenning, J B A1 - Richter, R J A1 - Jarvik, G P A1 - Furlong, C E T1 - Polymorphisms in the human paraoxonase (PON1) promoter. Y1 - 2001/02/ N1 - R826886C002 N1 - R826886 JF - PHARMACOGENETICS J1 - PHARMACOGENETICS VL - 11 IS - 1 SP - 77 EP - 84 ER - TY - JOUR A1 - Brophy, V H A1 - Jampsa, R L A1 - Clendenning, J B A1 - McKinstry, L A A1 - Jarvik, G P A1 - Furlong, C E T1 - Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Y1 - 2001/06/ N1 - R826886C002 N1 - R826886 N1 - R831709 JF - AMERICAN JOURNAL OF HUMAN GENETICS J1 - AM J HUM GENET J2 - American Journal of Human Genetics J3 - American Journal of Human Genetics J4 - American Journal of Human Genetics VL - 68 IS - 6 SP - 1428 EP - 1436 ER - TY - JOUR A1 - Costa, L G A1 - Li, W F A1 - Richter, R J A1 - Shih, D M A1 - Lusis, A A1 - Furlong, C E T1 - The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism. Y1 - 1999/05/14 N1 - R826886C002 N1 - R826886 JF - CHEMICO-BIOLOGICAL INTERACTIONS J1 - CHEM-BIOL INTERACT VL - 119-120 SP - 429 EP - 438 ER - TY - JOUR A1 - Costa, L G T1 - The emerging field of ecogenetics. Y1 - 2000/02/ N1 - R826886C002 N1 - R826886 JF - NEUROTOXICOLOGY J1 - NEUROTOXICOLOGY VL - 21 IS - 1-2 SP - 85 EP - 89 ER - TY - JOUR A1 - Costa, L G A1 - Richter, R J A1 - Li, W A1 - Cole, T A1 - Guizzetti, M A1 - Furlong, C E T1 - Paraoxonase (PON1) as a biomarker of susceptibility for organophosphate toxicity. Y1 - 2003/01/ N1 - R826886C002 N1 - R826886 N1 - R831709C002 N1 - R831709 JF - BIOMARKERS J1 - BIOMARKERS VL - 8 IS - 1 SP - 1 EP - 12 ER - TY - JOUR A1 - Costa, L G A1 - Cole, T B A1 - Jarvik, G P A1 - Furlong, C E T1 - Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Y1 - 2003// N1 - R826886C002 N1 - R826886 N1 - R831709C002 N1 - R831709 JF - ANNUAL REVIEW OF MEDICINE J1 - ANNU REV MED VL - 54 SP - 371 EP - 392 ER - TY - JOUR A1 - Furlong, C E A1 - Li, W F A1 - Brophy, V H A1 - Jarvik, G P A1 - Richter, R J A1 - Shih, D M A1 - Lusis, A J A1 - Costa, L G T1 - The PON1 gene and detoxication. Y1 - 2000/08/ N1 - R826886C002 N1 - R826886 JF - NEUROTOXICOLOGY J1 - NEUROTOXICOLOGY VL - 21 IS - 4 SP - 581 EP - 587 ER - TY - JOUR A1 - Furlong, C E A1 - Li, W F A1 - Richter, R J A1 - Shih, D M A1 - Lusis, A J A1 - Alleva, E A1 - Costa, L G T1 - Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1). Y1 - 2000/02/ N1 - R826886C002 N1 - R826886 JF - NEUROTOXICOLOGY J1 - NEUROTOXICOLOGY VL - 21 IS - 1-2 SP - 91 EP - 100 ER - TY - JOUR A1 - Furlong, C E A1 - Cole, T B A1 - Jarvik, G P A1 - Costa, L G T1 - Pharmacogenomic considerations of the paraoxonase polymorphisms. Y1 - 2002/05/ N1 - R826886C002 N1 - R826886 JF - PHARMACOGENETICS J1 - PHARMACOGENETICS VL - 3 IS - 3 SP - 341 EP - 348 ER - TY - JOUR A1 - Furlong, C E A1 - Li, W A1 - Shih, D M A1 - Lusis, A J A1 - Richter, R J A1 - Costa, L G T1 - Genetic factors in susceptibility: serum PON1 variation between individuals and species. Y1 - 2002// N1 - R826886C002 N1 - R826886 JF - HUMAN AND ECOLOGICAL RISK ASSESSMENT J1 - HUM ECOL RISK ASSESS VL - 8 IS - 1 SP - 31 EP - 43 ER - TY - JOUR A1 - Li, W F A1 - Costa, L G A1 - Richter, R J A1 - Hagen, T A1 - Shih, D M A1 - Tward, A A1 - Lusis, A J A1 - Furlong, C E T1 - Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Y1 - 2000/12/ N1 - R826886C002 N1 - R826886 JF - PHARMACOGENETICS J1 - PHARMACOGENETICS VL - 10 IS - 9 SP - 767 EP - 779 ER -